AAAAAA

   
Results: 1-11 |
Results: 11
THE IDENTIFICATION OF RISK-FACTORS ASSOCIATED WITH PERSISTENT PAIN FOLLOWING HERPES-ZOSTER
Authors: WHITLEY RJ SHUKLA S CROOKS RJ
Citation: Rj. Whitley et al., THE IDENTIFICATION OF RISK-FACTORS ASSOCIATED WITH PERSISTENT PAIN FOLLOWING HERPES-ZOSTER, The Journal of infectious diseases, 178, 1998, pp. 71-75
TREATMENT OF ACUTE HERPES-ZOSTER - EFFECT OF EARLY (LESS-THAN-48 H) VERSUS LATE (48-72 H) THERAPY WITH ACYCLOVIR AND VALACICLOVIR ON PROLONGED PAIN
Authors: WOOD MJ SHUKLA S FIDDIAN AP CROOKS RJ
Citation: Mj. Wood et al., TREATMENT OF ACUTE HERPES-ZOSTER - EFFECT OF EARLY (LESS-THAN-48 H) VERSUS LATE (48-72 H) THERAPY WITH ACYCLOVIR AND VALACICLOVIR ON PROLONGED PAIN, The Journal of infectious diseases, 178, 1998, pp. 81-84
THE INTRODUCTION OF PALLADIUM INTO SUPERCONDUCTING CUPRATE MATERIALS
Authors: CROOKS RJ CURRIE DB HECTOR AL WELLER MT
Citation: Rj. Crooks et al., THE INTRODUCTION OF PALLADIUM INTO SUPERCONDUCTING CUPRATE MATERIALS, Physica. C, Superconductivity, 282, 1997, pp. 449-450
VALACICLOVIR VERSUS ACYCLOVIR IN PATIENT INITIATED TREATMENT OF RECURRENT GENITAL HERPES - A RANDOMIZED, DOUBLE-BLIND CLINICAL-TRIAL
Authors: BODSWORTH NJ CROOKS RJ BORELLI S VEJLSGAARD G PAAVONEN J WORM AM UEXKULL N ESMANN J STRAND A INGAMELLS AJ GIBB A
Citation: Nj. Bodsworth et al., VALACICLOVIR VERSUS ACYCLOVIR IN PATIENT INITIATED TREATMENT OF RECURRENT GENITAL HERPES - A RANDOMIZED, DOUBLE-BLIND CLINICAL-TRIAL, Genitourinary medicine, 73(2), 1997, pp. 110-116
VALACICLOVIR VERSUS ACYCLOVIR IN THE TREATMENT OF FIRST-EPISODE GENITAL HERPES INFECTION - RESULTS OF AN INTERNATIONAL, MULTICENTER, DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL
Authors: FIFE KH BARBARASH RA RUDOLPH T DEGREGORIO B ROTH R CAMERON WB STEVENS S TYRING S LAPPIN M YOCKEY C HANSON M LONG B SNYDER F RAFFANTI S NELSON M TIPTON N BRITTON T COLLINS R GONTERO E GEIL J WRIGHT B DAVIDBAJAR K HANDSFIELD H GRIFFITH S DAVIS R LALONDE J WRIGHT L MCCRACKEN C WADDELL R PATEL R MINNS G BRIEFER C CHILD D KELSEY J WOOLLEY P SNOW R GARLAND S CURLESS E THATCHER S GUILL M HAVLICHEK D GOH B LUZZI G WOOD P REZA L STABLER C KATZ D GRANT D CAMPBELL J SEDLACEK T VANAMERONGEN D CHEETHAM D WESP J BINGHAM J DIX L CROOKS RJ
Citation: Kh. Fife et al., VALACICLOVIR VERSUS ACYCLOVIR IN THE TREATMENT OF FIRST-EPISODE GENITAL HERPES INFECTION - RESULTS OF AN INTERNATIONAL, MULTICENTER, DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL, Sexually transmitted diseases, 24(8), 1997, pp. 481-486
THE SYNTHESES AND STRUCTURES OF THE COMPLEX OXIDE CARBONATES BA11PD11O20(CO3)(2) AND BA88NI87O156(CO3)(19)
Authors: CROOKS RJ WELLER MT
Citation: Rj. Crooks et Mt. Weller, THE SYNTHESES AND STRUCTURES OF THE COMPLEX OXIDE CARBONATES BA11PD11O20(CO3)(2) AND BA88NI87O156(CO3)(19), Journal of solid state chemistry, 128(2), 1997, pp. 220-227
MULTIPLE-DOSE NETIVUDINE, A POTENT ANTI-VARICELLA ZOSTER VIRUS AGENT,IN HEALTHY ELDERLY VOLUNTEERS AND PATIENTS WITH SHINGLES
Authors: PECK RW CROME P WOOD MJ MCKENDRICK MW BANNISTER B MANDAL BK CROOKS RJ
Citation: Rw. Peck et al., MULTIPLE-DOSE NETIVUDINE, A POTENT ANTI-VARICELLA ZOSTER VIRUS AGENT,IN HEALTHY ELDERLY VOLUNTEERS AND PATIENTS WITH SHINGLES, Journal of antimicrobial chemotherapy, 37(3), 1996, pp. 583-597
VALACICLOVIR - A REVIEW OF ITS POTENTIAL IN THE MANAGEMENT OF GENITALHERPES
Authors: CROOKS RJ
Citation: Rj. Crooks, VALACICLOVIR - A REVIEW OF ITS POTENTIAL IN THE MANAGEMENT OF GENITALHERPES, Antiviral chemistry & chemotherapy, 6, 1995, pp. 39-44
A PHARMACOKINETIC AND SAFETY EVALUATION OF A 28 DAY COURSE OF ORAL ACYCLOVIR IN ELDERLY PATIENTS WITH HERPES-ZOSTER
Authors: MOSS PJ WOOD MJ CROOKS RJ GALLAGHER J MCKENDRICK MW
Citation: Pj. Moss et al., A PHARMACOKINETIC AND SAFETY EVALUATION OF A 28 DAY COURSE OF ORAL ACYCLOVIR IN ELDERLY PATIENTS WITH HERPES-ZOSTER, Journal of antimicrobial chemotherapy, 36(1), 1995, pp. 271-273
VALACICLOVIR - A REVIEW OF A PROMISING NEW ANTIHERPES AGENT
Authors: CROOKS RJ MURRAY A
Citation: Rj. Crooks et A. Murray, VALACICLOVIR - A REVIEW OF A PROMISING NEW ANTIHERPES AGENT, Antiviral chemistry & chemotherapy, 5, 1994, pp. 31-37
PRELIMINARY PHARMACOKINETICS AND SAFETY OF 882C87 IN PATIENTS WITH HERPES-ZOSTER
Authors: WOOD MJ MCKENDRICK MW BANNISTER B MANDAL BK PECK RW CROOKS RJ
Citation: Mj. Wood et al., PRELIMINARY PHARMACOKINETICS AND SAFETY OF 882C87 IN PATIENTS WITH HERPES-ZOSTER, Journal of medical virology, 1993, pp. 154-157
Risultati: 1-11 |